DeRenzo Lab Team

Dr. Christopher DeRenzo leads the study of CAR T cell therapy in the treatment of solid tumors at St. Jude. He is an Assistant Faculty member and earned his MD from Rutgers Robert Wood Johnson Medical School and his MBA from Rutgers Business School. The translational and reverse-translational approach of his laboratory is one that fosters a spirit of collaboration and dedication to the advancement of treatments for children with solid tumors.